BAIRD MEDICAL INVESTMENT HOLDINGS LIMITED

NASDAQ: BDMD (Baird Medical Investment Holdin)

Kemas kini terakhir: 26 Dec, 2024, 12:23AM

1.77

-0.17 (-8.98%)

Penutupan Terdahulu 1.94
Buka 2.05
Jumlah Dagangan 65,019
Purata Dagangan (3B) 66,125
Modal Pasaran 63,177,852
Harga / Pendapatan (P/E TTM) 5.05
Harga / Jualan (P/S) 5.49
Harga / Buku (P/B) 4.67
Julat 52 Minggu
1.42 (-19%) — 13.52 (665%)
Margin Keuntungan 37.96%
Margin Operasi (TTM) 38.74%
EPS Cair (TTM) 0.350
Pertumbuhan Hasil Suku Tahunan (YOY) 13.80%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 85.80%
Jumlah Hutang/Ekuiti (D/E MRQ) 39.53%
Nisbah Semasa (MRQ) 2.10
Aliran Tunai Operasi (OCF TTM) -5.62 M

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Devices (US) Bercampur Bercampur
Medical Devices (Global) Bercampur Bercampur
Stok Baird Medical Investment Holdin - -

AISkor Stockmoo

1.3
Konsensus Penganalisis 0.0
Aktiviti Orang Dalam NA
Volatiliti Harga 0.5
Purata Bergerak Teknikal 2.5
Osilator Teknikal 2.0
Purata 1.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
BDMD 63 M - 5.05 4.67
CBLL 925 M - - -
DHAI 84 M - - 3.03
MDAI 62 M - - -
ADGM 24 M - - 0.180
QTI 9 M - - -

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Sektor Healthcare
Industri Medical Devices
% Dimiliki oleh Orang Dalam 22.16%
% Dimiliki oleh Institusi 0.99%

Pemilikan

Nama Tarikh Syer Dipegang
Dryden Capital, Llc 30 Jun 2024 638,277

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
30 Dec 2024 Pengumuman Baird Medical Showcases Innovations in Endocrine Care at 2024 Southern Yue Forum
23 Dec 2024 Pengumuman Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment
17 Dec 2024 Pengumuman Baird Medical Sponsored and Participated in 2024 Guangdong Thyroid Surgery Committee Annual Meeting
16 Dec 2024 Pengumuman Baird-Sponsored Microwave Ablation Training Advances Innovation in Thyroid Care
10 Dec 2024 Pengumuman Baird Medical Charts 2025 Strategic Vision Following Milestone Year
25 Nov 2024 Pengumuman Baird Medical Sponsored and Showcased Microwave Ablation (MWA) Technology at the 7th Thyroid Disease Forum in China
11 Nov 2024 Pengumuman Baird Medical Showcased Microwave Ablation Technology at Massachusetts Society of Otolaryngology Event
04 Nov 2024 Pengumuman Baird Medical's Advanced Microwave Ablation Solutions Captivate Attendees at the 2024 ATA Meeting
28 Oct 2024 Pengumuman Baird Medical Advances Global Academic Collaboration in Thyroid Health
24 Oct 2024 Pengumuman Baird Medical Proudly Invited to Showcase Microwave Ablation Technology at the ACS Clinical Congress
14 Oct 2024 Pengumuman Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting
11 Oct 2024 Pengumuman Baird Medical Announces Preliminary Financial Results for the Six Months Ended June 30, 2024
09 Oct 2024 Pengumuman Baird Medical Lists in the U.S. on the Nasdaq Exchange
08 Oct 2024 Pengumuman Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda